156 related articles for article (PubMed ID: 16168596)
1. Administration of secretin for autism alters dopamine metabolism in the central nervous system.
Toda Y; Mori K; Hashimoto T; Miyazaki M; Nozaki S; Watanabe Y; Kuroda Y; Kagami S
Brain Dev; 2006 Mar; 28(2):99-103. PubMed ID: 16168596
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of secretin for the treatment of autism].
Toda Y; Mori K; Hashimoto T; Miyazaki M; Kuroda Y
No To Hattatsu; 2004 Jul; 36(4):289-95. PubMed ID: 15272612
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism.
Narayan M; Srinath S; Anderson GM; Meundi DB
Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):630-5. PubMed ID: 7687150
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid biopterin and biogenic amine metabolites during oral R-THBP therapy for infantile autism.
Komori H; Matsuishi T; Yamada S; Yamashita Y; Ohtaki E; Kato H
J Autism Dev Disord; 1995 Apr; 25(2):183-93. PubMed ID: 7559284
[TBL] [Abstract][Full Text] [Related]
5. Estimation of monoamine and cyclic-AMP turnover and amino acid concentrations of spinal fluid in autistic children.
Winsberg BG; Sverd J; Castells S; Hurwic M; Perel JM
Neuropediatrics; 1980 Aug; 11(3):250-5. PubMed ID: 6158716
[TBL] [Abstract][Full Text] [Related]
6. [Disturbances in dopamine metabolism in autistic children: results of clinical tests and urinary dosages of homovanilic acid (HVA)].
Garreau B; Barthelemy C; Domenech J; Sauvage D; Muh JP; Lelord G; Callaway E
Acta Psychiatr Belg; 1980; 80(3):249-65. PubMed ID: 6111177
[TBL] [Abstract][Full Text] [Related]
7. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.
Poceta JS; Parsons L; Engelland S; Kripke DF
Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium.
Ramirez-Bermudez J; Ruiz-Chow A; Perez-Neri I; Soto-Hernandez JL; Flores-Hernandez R; Nente F; Montes S; Rios C
Gen Hosp Psychiatry; 2008; 30(4):337-43. PubMed ID: 18585537
[TBL] [Abstract][Full Text] [Related]
9. Decrease in 6R-5,6,7,8-tetrahydrobiopterin content in cerebrospinal fluid of autistic patients.
Tani Y; Fernell E; Watanabe Y; Kanai T; Långström B
Neurosci Lett; 1994 Nov; 181(1-2):169-72. PubMed ID: 7898761
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
[TBL] [Abstract][Full Text] [Related]
11. Use of secretin in the treatment of childhood autism.
Kamińska B; Czaja M; Kozielska E; Mazur E; Korzon M
Med Sci Monit; 2002 Jan; 8(1):RA22-6. PubMed ID: 11782669
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of transdermal secretin on behavior of children with autism.
Ratliff-Schaub K; Carey T; Reeves GD; Rogers MA
Autism; 2005 Jul; 9(3):256-65. PubMed ID: 15937041
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic dsyfunction in Tourette syndrome.
Singer HS; Butler IJ; Tune LE; Seifert WE; Coyle JT
Ann Neurol; 1982 Oct; 12(4):361-6. PubMed ID: 6184010
[TBL] [Abstract][Full Text] [Related]
14. Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study.
Lightdale JR; Hayer C; Duer A; Lind-White C; Jenkins S; Siegel B; Elliott GR; Heyman MB
Pediatrics; 2001 Nov; 108(5):E90. PubMed ID: 11694674
[TBL] [Abstract][Full Text] [Related]
15. CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome.
Earley CJ; Hyland K; Allen RP
Mov Disord; 2001 Jan; 16(1):144-9. PubMed ID: 11215576
[TBL] [Abstract][Full Text] [Related]
16. A case of 6-pyruvoyl-tetrahydropterin synthase deficiency demonstrates a more significant correlation of L-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels.
Ogawa A; Kanazawa M; Takayanagi M; Kitani Y; Shintaku H; Kohno Y
Brain Dev; 2008 Jan; 30(1):82-5. PubMed ID: 17590551
[TBL] [Abstract][Full Text] [Related]
17. Circadian changes in CSF dopaminergic measures in restless legs syndrome.
Earley CJ; Hyland K; Allen RP
Sleep Med; 2006 Apr; 7(3):263-8. PubMed ID: 16564215
[TBL] [Abstract][Full Text] [Related]
18. CSF neurotransmitter metabolites and neuropsychiatric symptomatology in patients with normal pressure hydrocephalus.
Markianos M; Lafazanos S; Koutsis G; Sfagos C; Seretis A
Clin Neurol Neurosurg; 2009 Apr; 111(3):231-4. PubMed ID: 19046799
[TBL] [Abstract][Full Text] [Related]
19. [Usual values for 5-hydroxy-indol acetic acid and homovanillic acid in cerebrospinal fluid].
Dhondt JL; Forzy G
Ann Biol Clin (Paris); 2003; 61(1):69-75. PubMed ID: 12604388
[TBL] [Abstract][Full Text] [Related]
20. Improved social and language skills after secretin administration in patients with autistic spectrum disorders.
Horvath K; Stefanatos G; Sokolski KN; Wachtel R; Nabors L; Tildon JT
J Assoc Acad Minor Phys; 1998; 9(1):9-15. PubMed ID: 9585670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
